FCEPL
BUYFrieslandCampina Engro Pakistan
Food & Personal Care · 0.36% of the KSE-100
Price
Rs 84.96
Market cap
Rs 20.8bn
12-month return
+61.6%
Rank
20 of 101
Why the engine ranks it here
FrieslandCampina Engro Pakistan (FCEPL) screens as attractive relative to the rest of the KSE-100, ranking 20 of 101 on a composite score of 63/100.
FrieslandCampina Engro Pakistan sits in the Food & Personal Care sector and scores best on growth (69/100), weakest on price trend (51/100). At PKR 84.96 the shares trade on a P/E of 0.3x, 0.16x book, a 60.0% dividend yield. The Piotroski F-Score is 8 of 9 (very strong) and the Altman Z''-Score is 7.02 (financially sound).
What it does well
FCEPL has compounded revenue at 25.9% a year over three years.
Growth
FCEPL returns 30.9% on invested capital.
Profitability & earnings quality
FCEPL earns 56.1% on shareholders' money, well ahead of its Food & Personal Care peers.
Profitability & earnings quality
What holds it back
FCEPL books 4.8% of assets as accruals, so profit is running ahead of cash.
Profitability & earnings quality
FCEPL has lagged the KSE-100 by -14.9% over six months.
Price trend
FCEPL holds only 1.55x of current assets against current liabilities.
Balance-sheet strength
What would change this view
- → the price reclaiming its 200-day average on rising volume
Five-pillar breakdown
Each pillar scores the company against sector peers, where 50 is the sector average.
The classic screens
Piotroski tests nine accounting facts about improvement; Altman scores the distance from financial distress.
Piotroski F-Score
8 / 9
very strong · 8 of 9 tests passed
Altman Z''-Score
7.02
safe zone · safe above 5.85
Profitable on assets
ROA 14.7%
Cash generative
CFO PKR 41,402m
Returns improving
ROA 14.7% vs 8.5% a year ago
Earnings backed by cash
CFO PKR 41,402m vs profit PKR 61,668m
Deleveraging
debt/assets 0.24 vs 0.25
Liquidity improving
current ratio 1.55 vs 1.47
Margin expanding
gross margin 35.0% vs 27.9%
Assets working harder
asset turnover 2.08x vs 2.01x
No shareholder dilution
245m shares vs 245m
Altman components
Price history
Weekly closes. Beta 0.55 against the index, annualised volatility 25%, RSI 53.
Reported accounts
The last twelve quarters as filed, in PKR millions. The publication date is what the engine uses to decide when a figure became knowable.
| Quarter | Revenue | Gross profit | Operating | Net income | EPS | Filed |
|---|---|---|---|---|---|---|
| 2025 Q4 | Rs 244.4bn | Rs 82.9bn | Rs 25.8bn | Rs 16.5bn | 67.59 | 2026-04-30 |
| 2025 Q3 | Rs 246.7bn | Rs 96.4bn | Rs 31.2bn | Rs 20.6bn | 84.19 | 2025-11-14 |
| 2025 Q2 | Rs 235.2bn | Rs 65.4bn | Rs 19.0bn | Rs 12.1bn | 49.42 | 2025-08-14 |
| 2025 Q1 | Rs 204.2bn | Rs 79.4bn | Rs 25.7bn | Rs 16.6bn | 67.87 | 2025-05-15 |
| 2024 Q4 | Rs 184.4bn | Rs 63.9bn | Rs 20.0bn | Rs 12.3bn | 50.43 | 2025-04-30 |
| 2024 Q3 | Rs 179.8bn | Rs 48.4bn | Rs 13.8bn | Rs 7.4bn | 30.33 | 2024-11-14 |
| 2024 Q2 | Rs 180.7bn | Rs 47.9bn | Rs 13.6bn | Rs 6.9bn | 28.35 | 2024-08-14 |
| 2024 Q1 | Rs 165.7bn | Rs 41.4bn | Rs 11.4bn | Rs 5.6bn | 22.94 | 2024-05-15 |
| 2023 Q4 | Rs 148.5bn | Rs 50.4bn | Rs 15.7bn | Rs 8.5bn | 34.89 | 2024-04-29 |
| 2023 Q3 | Rs 145.9bn | Rs 27.8bn | Rs 6.6bn | Rs 2.2bn | 9.08 | 2023-11-14 |
| 2023 Q2 | Rs 147.8bn | Rs 46.0bn | Rs 13.9bn | Rs 7.6bn | 30.84 | 2023-08-14 |
| 2023 Q1 | Rs 136.2bn | Rs 40.9bn | Rs 12.2bn | Rs 6.6bn | 27.01 | 2023-05-15 |
Ranked against Food & Personal Care
Every peer in the same sector, ordered by composite score. These are the companies whose ratios set this one's z-scores.
Scored as of 31 December 2025. Generated by an automated screen for research and educational use. Not investment advice, and not a substitute for a SECP-licensed adviser.